Friday, December 6, 2013

Gender Differences in Patients with Intravenous Thrombolytic and Conservative Treatment for Acute Ischemic Stroke


Stoke is the leading cause of death and disability worldwide. For decades, scientists have been developing techniques with goals to lower the incidence of stroke or eliminate it entirely. Biomedical engineers and Doctors at the Paracelsus Medical University have theorized that administering thrombolysis into a stroke inclined patient might reduce the chances the patient will have another stroke so an experiment was developed to test for validity. In the experiment conducted by analysts at the Paracelsus Medical University, over 2800 Ischemic stroke patients were admitted to the stroke unit and tested using thrombolytic treatment through an IV. After all the testing had commenced, results displayed a significant improvement in both genders after thrombolytic treatment, almost a 22.9% turnover. This being said, women had less of an improvement when it came to thrombolytic treatment showing that the utility of the thrombolytic treatment could be linked to the sex of a the patient.

Death by stroke has been tied throughout my family lineage, which is one of the reasons I found this article interesting.  There are many theories saying that stroke is linked to genetics and can be passed down a family line so any improvement for stroke patients could be used on me and my future family.

http://www.omicsonline.org/gender-differences-in-patients-with-intravenous-thrombolytic-and-conservative-treatment-for-acute-ischemic-stroke-2155-9562.1000117.php?aid=1627

No comments:

Post a Comment